StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening

  StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening By StemExpress January 16, 2023 StemExpress has published its full Clinical Commercial Solutions Guide and launched their new Clinical Donor Screening services.  Now, researchers and therapeutic developers can discover how StemExpress is utilizing a nationwide & coast-to-coast footprint of privately owned and operated collection facilities to support the…

For More Information

StemExpress Launches CellsExpress Bulk Cell Isolation

StemExpress Launches CellsExpress Bulk Cell Isolation Researchers can maximize their isolated cell output, saving valuable time and budget better spent on their research. FOLSOM, Calif. , /PRNewswire/ — As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk…

For More Information

ISCT Meeting

ISCT Meeting 2022 May 4-7, 2022 StemExpress is excited to attend the ISCT Meeting, May 4-7, 2022, where we will join the leaders in cell and gene therapy to discuss the future of clinical research. As more commercial therapies are moving to approval stages, the need for clinical-level partners to support these projects is at…

For More Information

ISSCR Annual Meeting 2022

April 15-18, 2022 San Francisco, CA StemExpress is excited to attend the ISSCR Annual Meeting, April 15-18, 2022, where we will discuss process acceleration in the development of life-saving therapies, from R&D to clinical commercialization. With vast expertise in the pre-clinical, clinical, and healthcare space, StemExpress knows the importance of moving projects through commercialization to…

For More Information

AARC Annual Meeting 2022

March 11, 2022 (NEW ORLEANS, LA) – StemExpress is excited to attend the AACR Annual Meeting, April 8-13, 2022, where we will join the innovative minds in the clinical space to discuss the importance of picking partners from product development to clinical commercialization. As more cancer therapies move through clinical approval, our company mission is…

For More Information

StemExpress Opens Facility In Northern Nevada

RENO, Nev., April 5, 2021 /PRNewswire/ — StemExpress is excited to announce that we will be opening our eighth facility with our newest location in Reno, Nevada. The property development will include a state-of-the-art cell collection center as well as a large-scale warehouse that contains a centralized shipping location for the company. The site will also be a new…

For More Information

Coronavirus (COVID-19) Alert

StemExpress provides full-service COVID-19 testing for individuals, families, public health agencies, and businesses. We have integrated gold standard PCR testing into our existing stem cell laboratories, in an effort to protect the health, safety, and economic vitality of our communities. In addition, we have launched a portfolio of biospecimen products to aid in COVID-19 research.

For More Information

StemExpress Exhibiting at the 27th International Molecular Medicine Tri-Conference

[vc_row][vc_column][vc_column_text] ABOUT THE EVENT StemExpress Exibiting at the 27th International Molecular Medicine Tri-Conference The event and conference team at Cambridge Healthtech Institute (CHI) proudly presents the 27th International Molecular Medicine Tri-Conference at the beautifully remodeled Moscone Convention Center in San Francisco’s downtown district. This dedicated team, with a long tenure, continues to host one of…

For More Information